ELEVAI Labs Inc. (ELAB) has issued an update.
Dr. Jordan Plews has announced his resignation as CEO of the Company, effective June 21, 2024, but will continue leading the firm’s subsidiaries Elevai Skincare and Elevai Biosciences. The Company also terminated its chief marketing and commercial officers as part of a restructuring to streamline operations. Meanwhile, CFO Graydon Bensler has been appointed as the new non-employee CEO with unchanged compensation, and Braeden Lichti has been named non-executive chairman of the Board, both through consulting agreements with their respective firms.
See more insights into ELAB stock on TipRanks’ Stock Analysis page.
